However, DPP-IV inhibitors as sitagliptin, through plasma GLP-1 stabilization and insulin control of hyperglycemia/lipidemia, reduced the cardiac pro-apoptotic/necrotic, hypertrophic and fibrotic expression in a similar way to metformin. This evidence concerns the gene GCG and hyperlipidemia.